Mary Ann Moon writing in Rheumatology News reported on the conclusions of two studies. One concern rheumatologists have had is what to do about pregnant patients who are on TNF inhibitors. Two observational studies (one from University California San Francisco and the other from Erasmus Medical Center, Rotterdam) provide some information.
The upshot is that stopping Remicade and Humira at the end of the second trimester reduces the amount of antibody transferred to the infant and shortens the time for the infant to clear the antibody. Cimzia doesn’t need to be stopped since it doesn’t cross the placenta.
Comment: This is important since it reduces the likelihood of opportunistic infection in the infant.
For more information on arthritis treatments and other arthritis problems, go to:
Just go here Contact